Actualités Institute of Biomedical Research Corporation New (PK) - MRES | Actions OTCMarkets

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ______________ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR...

MRES ANNOUNCES RESUMPTION OF THE BUYOUT OFFER AT $0.15 FROM AURIC

MRES ANNOUNCES RESUMPTION OF THE BUYOUT OFFER AT $0.15 FROM AURIC PR Newswire KAZAN, Russian Federation, March 30 KAZAN, Russian Federation...

Neuro-Biotech Corp. Representative to Meet with Russian Deputy Economic Development Minister Andrei Slepnev on Monday

Neuro-Biotech Corp. Representative to Meet with Russian Deputy Economic Development Minister Andrei Slepnev on Monday PR Newswire BASEL...

President of Credo-TM Joins Neuro-Biotech Corp. Board of Directors

President of Credo-TM Joins Neuro-Biotech Corp. Board of Directors PR Newswire BASEL, Switzerland, March 24 BASEL, Switzerland, March 24...

Neuro-Biotech Corp. Completes Its Due Diligence

Neuro-Biotech Corp. Completes Its Due Diligence PR Newswire BASEL, Switzerland, March 23 BASEL, Switzerland, March 23 /PRNewswire/...

Neuro-Biotech Corp. Updates on Due Diligence

Neuro-Biotech Corp. Updates on Due Diligence PR Newswire BASEL, Switzerland, Feb. 28 BASEL, Switzerland, Feb. 28 /PRNewswire/ - Neuro-Biotech...

Neuro-Biotech Corp.: Conditions of Unsolicited Offer

Neuro-Biotech Corp.: Conditions of Unsolicited Offer PR Newswire BASEL, Switzerland, Feb. 16 BASEL, Switzerland, Feb. 16 /PRNewswire/...

Neuro-Biotech Corp. Provides Details on Unsolicited Offer

Neuro-Biotech Corp. Provides Details on Unsolicited Offer PR Newswire BASEL, Switzerland, Feb. 15 BASEL, Switzerland, Feb. 15...

Neuro-Biotech Corp: THE BOARD OF DIRECTORS ACCEPTED THE 15 CENT OFFER

Neuro-Biotech Corp: THE BOARD OF DIRECTORS ACCEPTED THE 15 CENT OFFER PR Newswire BASEL, Switzerland, Feb. 15 BASEL, Switzerland, Feb. 15...

Neuro-Biotech Corp Provides Updates on Unsolicited Offer

Neuro-Biotech Corp Provides Updates on Unsolicited Offer PR Newswire BASEL, Switzerland, Feb. 14 BASEL, Switzerland, Feb. 14 /PRNewswire/...

Neuro-Biotech Corp Announces Unsolicited Offer

Neuro-Biotech Corp Announces Unsolicited Offer PR Newswire BASEL, Switzerland, Feb. 10 BASEL, Switzerland, Feb. 10 /PRNewswire-FirstCall/...

NEURO-BIOTECH CORP. ISSUES A CLARIFICATION OF THE PRESS RELEASE DATED FEBRUARY 8, 2011

NEURO-BIOTECH CORP. ISSUES A CLARIFICATION OF THE PRESS RELEASE DATED FEBRUARY 8, 2011 PR Newswire BASEL, Switzerland, Feb. 9 BASEL, Switzerland...

- Quarterly Report (10-Q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.20549 FORM 10-Q (Mark One) þ Quarterly Report Pursuant...

POST TRAUMATIC STRESS DISORDER: NEURO-BIOTECH ADDRESSES A FOCUSED APPROACH

POST TRAUMATIC STRESS DISORDER: NEURO-BIOTECH ADDRESSES A FOCUSED APPROACH PR Newswire BASEL, Switzerland, Feb. 9 BASEL, Switzerland, Feb. 9...

NEURO-BIOTECH CORP: MAJOR CONTRACT WITH ISRAEL

NEURO-BIOTECH CORP: MAJOR CONTRACT WITH ISRAEL PR Newswire BASEL, Switzerland, Feb. 8 BASEL, Switzerland, Feb. 8 /PRNewswire/ - Neuro-Biotech...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Institute of Biomedical Research Corporation New (PK) (MRES)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

MRES Actualités

- Current report filing (8-K)

MRES ANNOUNCES RESUMPTION OF THE BUYOUT OFFER AT $0.15 FROM AURIC

Neuro-Biotech Corp. Representative to Meet with Russian Deputy Economic Development Minister Andrei Slepnev on Monday

President of Credo-TM Joins Neuro-Biotech Corp. Board of Directors

Neuro-Biotech Corp. Completes Its Due Diligence

Neuro-Biotech Corp. Updates on Due Diligence

Neuro-Biotech Corp.: Conditions of Unsolicited Offer

Neuro-Biotech Corp. Provides Details on Unsolicited Offer

Neuro-Biotech Corp: THE BOARD OF DIRECTORS ACCEPTED THE 15 CENT OFFER

Neuro-Biotech Corp Provides Updates on Unsolicited Offer

Neuro-Biotech Corp Announces Unsolicited Offer

NEURO-BIOTECH CORP. ISSUES A CLARIFICATION OF THE PRESS RELEASE DATED FEBRUARY 8, 2011

- Quarterly Report (10-Q)

POST TRAUMATIC STRESS DISORDER: NEURO-BIOTECH ADDRESSES A FOCUSED APPROACH

NEURO-BIOTECH CORP: MAJOR CONTRACT WITH ISRAEL

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Institute of Biomedical Research Corporation New (PK) (MRES) Actualités

Institute of Biomedical Research Corporation New (PK) (MRES)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

MRES Actualités

- Current report filing (8-K)

MRES ANNOUNCES RESUMPTION OF THE BUYOUT OFFER AT $0.15 FROM AURIC

Neuro-Biotech Corp. Representative to Meet with Russian Deputy Economic Development Minister Andrei Slepnev on Monday

President of Credo-TM Joins Neuro-Biotech Corp. Board of Directors

Neuro-Biotech Corp. Completes Its Due Diligence

Neuro-Biotech Corp. Updates on Due Diligence

Neuro-Biotech Corp.: Conditions of Unsolicited Offer

Neuro-Biotech Corp. Provides Details on Unsolicited Offer

Neuro-Biotech Corp: THE BOARD OF DIRECTORS ACCEPTED THE 15 CENT OFFER

Neuro-Biotech Corp Provides Updates on Unsolicited Offer

Neuro-Biotech Corp Announces Unsolicited Offer

NEURO-BIOTECH CORP. ISSUES A CLARIFICATION OF THE PRESS RELEASE DATED FEBRUARY 8, 2011

- Quarterly Report (10-Q)

POST TRAUMATIC STRESS DISORDER: NEURO-BIOTECH ADDRESSES A FOCUSED APPROACH

NEURO-BIOTECH CORP: MAJOR CONTRACT WITH ISRAEL

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application